Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>A=Coleman, C. Norman$<.>)
Общее количество найденных документов : 40
Показаны документы с 1 по 20
 1-20    21-40  
1.
Coleman C.Norman Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity // J. Nat. Cancer Inst., 1988. Vol. 80, N 5.-С.310-317

2.
Radioimmunotherapy with alpha-particle-emitting immunoconjugates // Science, 1988. Vol. 240, N 4855.-С.1024-1026

3.
Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazole // Caucer Res., 1988. Vol. 48, N 12.-С.3528-3532

4.
Combined modality therapy using cytotoxic agents and radiation therapy // Amer. J. Clin. Oncol., 1988. Vol. 11, N 3.-С.304-312

5.
Coleman C.Norman Hypoxia in tumors: a paradigm for the approach to biochemical and physilodic heterogenity // J. Nat. Cancer Inst., 1988. Vol. 80, N 5.-С.310-317

6.
Effect of OH scavenging on the yield of radiation-induced dna double-strand breaks in isolated nuclei // Oxygen Radicals in Biol. and Med.. -New York, London, 1988.-С.429-432

7.
Stevenson Effects of nitroimidazoles on neuronal cells in vitro // Int. J. Radiat., Oncol., Biol., Phys., 1989. Vol. 16, N 5.-С.1225-1230

8.
Harris Jay R. Estimating the risk of second primary tumors following cancer treatment // J. Clin. Oncol., 1989. Vol. 7, N 1.-С.5-6

9.
Initial results of a phase I trial of continuous infusion SR 2508 (etanidazole): A radiation therapy oncology group study // Int. J. Radiat., Oncol. Biol., Phys., 1989. Vol. 16, N 4.-С.1085-1087А

10.
Prognostic factors for positive surgical staging in patients with Hodgkin's disease // J. Clin. Oncol., 1990. Vol. 8, N 2.-С.257-265

11.
Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) radiation therapy oncology group 83-03 // Int. J. Radiat., Oncol. Biol., Phys., 1990. Vol. 18, N 2.-С.389-393

12.
Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma // J. Nat. Cancer Inst, 1990. Vol. 82, N 24.-С.1918-1921

13.
Improved methodology for analyzing local and distant recurrence // J. Clin. Oncol., 1990. Vol. 8, N 3.-С.548-555

14.
Herman Terence S. Interaction of SR-4233 with hyperthermia and radiatc murine fibrosarcoma tumor system in vitro and in vivo // Cancer Res., 1990. Vol. 50, N 16.-С.5055-5059

15.
Modulation of alkylating agents by etanidazole and fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma // Cancer Res., 1991. Vol. 51, N 4.-С.1044-1091

16.
In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients // Environ. and Mol. Mutagenes, 1991. Vol. 18, N 1.-С.6-13

17.
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma // J. Nat. Cancer Inst., 1992. Vol. 84, N 3.-С.187-193

18.
X-irradiation, phorbol esters, and H[2]O[2] stimulate mitogen-activated protein kinase activity in NIH-3Т3 cells through the formation of reactive oxygen intermediates // Cancer Res., 1994. Vol. 54, N 1.-С.12-15

19.
Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas // Cancer, 1994. Vol. 73, N 12.-С.3029-3036

20.
Effect of cell cycle stage, dose rate and repair of sublethal damage on radiation-induced apoptosis in F9 teratocarcinoma cells // Radiat. Res., 1995. Vol. 144, N 1.-С.90-96

 1-20    21-40  
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)